Log in to search using one of your social media accounts:

 

FDA Panel Considers Gene Therapy for Hereditary Eye Disease

Title: FDA Panel Considers Gene Therapy for Hereditary Eye DiseaseCategory: Health NewsCreated: 10/10/2017 12:00:00 AMLast Editorial Review: 10/11/2017 12:00:00 AM
Source: MedicineNet Eyesight General - Category: Opthalmology Source Type: news

Related Links:

Publication date: Available online 13 July 2017 Source:Egyptian Journal of Medical Human Genetics Author(s): A.S. Odiba, V.E. Ottah, O.O. Anunobi, C.Y. Ukegbu, R. Uroko, C.U. Ottah, A.A. Edeke, K. Omeje
Source: Egyptian Journal of Medical Human Genetics - Category: Genetics & Stem Cells Source Type: research
Publication date: October 2017 Source:Cytotherapy, Volume 19, Issue 10 Author(s): Richard P. Harrison, Steven Ruck, Nicholas Medcalf, Qasim A. Rafiq Decentralized or “redistributed” manufacturing has the potential to revolutionize the manufacturing approach for cell and gene therapies (CGTs), moving away from the “Fordist” paradigm, delivering health care locally, customized to the end user and, by its very nature, overcoming many of the challenges associated with manufacturing and distribution of high volume goods. In departing from the traditional centralized model of manufacturing, decentralized...
Source: Cytotherapy - Category: Cytology Source Type: research
Publication date: Available online 25 September 2017 Source:Egyptian Journal of Medical Human Genetics Author(s): A.S. Odiba, V.E. Ottah, O.K. Iroha T-cell-based cancer immunotherapy by the transfer of cloned TCRs that are isolated from tumor penetrating T-cells becomes a possibility through NY-ESOc259; a human-derived affinity-enhanced TCR that provides a level of sufficiency in long-term safety and efficacy. NY-ESOc259 recognizes a peptide common to CTAs (LAGE-1 and NY-ESO-1) in melanoma. Risks associated with insertion related transformation in gene therapy have been alleviated through strategies that include the engin...
Source: Egyptian Journal of Medical Human Genetics - Category: Genetics & Stem Cells Source Type: research
An experimental gene therapy for a rare hereditary form of blindness is a step closer to reality. An FDA advisory panel voted unanimously Thursday to recommend approval of a groundbreaking treatment for people with a faulty gene that impairs vision. It would be the first gene therapy in the U.S. for an inherited disease. Dr. David Agus joins "CBS This Morning" to discuss how the treatment works and why it could be a new frontier in treating genetic disorders.
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
The FDA advisory committee gave a unanimous thumbs-up to gene therapy for one form of inherited blindness, paving the way for others.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Ophthalmology News Source Type: news
If approved, it would be the first gene therapy in the U.S. for an inherited disease
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
An FDA advisory panel weighed in on a therapy that can improve the vision of people with a rare genetic disorder called Leber's congenital amaurosis (LCA)
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
An experimental gene therapy for a rare hereditary form of blindness is a step closer to reality. An FDA advisory panel voted unanimously Thursday to recommend approval of a groundbreaking treatment for people with a faulty gene that impairs vision. It would be the first gene therapy in the U.S. for an inherited disease. Dr. David Agus joins "CBS This Morning" to discuss how the treatment works and why it could be a new frontier in treating genetic disorders.
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
Title: FDA Panel Supports Gene Therapy for Kids With Rare Eye DiseaseCategory: Health NewsCreated: 10/13/2017 12:00:00 AMLast Editorial Review: 10/13/2017 12:00:00 AM
Source: MedicineNet Eyesight General - Category: Opthalmology Source Type: news
A FDA panel may soon approve a gene therapy that could grant the gift of sight to young people with a rare type of inherited vision loss.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
More News: Eyes | Gene Therapy | Genetics | Opthalmology